About The Polyclinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
15
Celgene
4
Allergan
3
Eli Lilly and Company
3
SWOG Cancer Research Network
3
Boehringer Ingelheim
2
AIDS Malignancy Consortium
1
American Regent, Inc.
1
Complexa, Inc.
1
Crescendo Bioscience
1
ECOG-ACRIN Cancer Research Group
1
Clinical Trials at The Polyclinic
During the past decade, The Polyclinic conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 25 clinical trials were completed, i.e. on
average, 312.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
2007-08-01
2011-01-01
Completed
109
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
2006-01-01
2010-08-01
Completed
22
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2008-04-01
2015-07-01
Terminated
12
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
2006-06-01
2011-07-01
Completed
41
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
2007-06-01
2012-11-01
Terminated
72
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
2007-11-01
2015-10-01
Terminated
96
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Polyclinic" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Celgene" with 4 trials
sponsored, "Allergan" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "SWOG Cancer Research Network"
with 3 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Polyclinic"
#1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Arkana Labs" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at The Polyclinic
According to Clinical.Site data, the most researched conditions in "The Polyclinic" are
"Adenocarcinoma of the Gastroesophageal Junction" (2 trials), "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Multiple Sclerosis" (2 trials) and "Recurrent Melanoma" (2 trials). Many other conditions were trialed in "The Polyclinic" in a lesser frequency.
Clinical Trials Intervention Types at The Polyclinic
Most popular intervention types in "The Polyclinic" are "Drug" (35 trials), "Biological" (9 trials), "Other" (8 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "fluorouracil" (5 trials), "leucovorin calcium" (4 trials), "Bevacizumab" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.
Clinical Trials Genders at The Polyclinic
The vast majority of trials in "The Polyclinic" are
37 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Polyclinic
Currently, there are NaN active trials in "The Polyclinic".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 26 completed trials in The Polyclinic,
1 suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in The Polyclinic, 1 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".